Group 1 - Health 160 (02656) and Jinfang Pharmaceutical-B (02595) are currently in the process of public offering, with significant oversubscription levels reported [1] - As of September 11, a total of HKD 89.9819 billion has been borrowed by brokers for Health 160, resulting in an oversubscription of over 178 times [1][2] - For Jinfang Pharmaceutical-B, brokers have borrowed HKD 92.9193 billion, leading to an oversubscription of over 57.8 times [1][2] Group 2 - The total amount raised for Health 160 is HKD 0.5 billion, while Jinfang Pharmaceutical-B has raised HKD 1.58 billion [2] - Major brokers involved in the borrowing for Health 160 include Futu, Huatai, and Yaocai, with Futu contributing HKD 41.75 billion [2] - For Jinfang Pharmaceutical-B, the largest contributions come from Futu and Huatai, amounting to HKD 52.90 billion and HKD 17.00 billion respectively [2]
新股孖展统计 | 9月11日